i






Public Title Status Last Date Modified
An extension study to provide treatment with Herceptin® or TX05 and assess continued safety and immunogenicity in subjects with HER2-positive early breast cancer following core study TX05-03. . . . Ongoing 16 Jul 2020
An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients with Open Angle Glaucoma or Ocular Hypertension . . . Ongoing 02 Feb 2021
An immunotherapy and a device used together to treat women with precancerous cells on the cervix caused by human papillomavirus (HPV) . . . Ongoing 19 Sep 2019
An international, multicentre, observational, prospective, longitudinal cohort study to assess the impact of integrated upper limb spasticity management including the use of bont-A injections on patie . . . Completed 15 Jun 2020
An International, Observational, Prospective Study on Long-term Response to Botulinum toxin type A (BoNT-A) Injections in Subjects Suffering from Idiopathic Cervical Dystonia (CD) - Pharmacoeconomic I . . . Completed 27 Aug 2019
An Open-Label, comparative, single dose, clinical phase 1 study to assess the safety and tolerability of Typhiod Conjugate Vaccine (EuTCV) in Healthy adults . . . Completed 02 Aug 2019
An Open-Label, Non-Randomized, Multi-Center Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegcetacoplan in the Treatment of Paroxysmal Nocturnal Hemoglubinuria (PNH) . . . Ongoing 25 Jun 2021
Application of Stem Cells for Diabetic Foot Wounds Ongoing 09 Jul 2019
ARISE: A multi-center prospective non-interventional study investigating the clinical effectiveness of Ryzodeg® (Insulin Degludec/Insulin Aspart) in patients with type 2 diabetes mellitus in a real w . . . Completed 06 May 2021
ATEZOLIZUMAB UNDER REAL-WORLD CONDITIONS IN PATIENTS TREATED IN ROUTINE CLINICAL PRACTICE Ongoing 06 Jul 2021
Avigan Trial Ongoing 11 Sep 2020
B-Clear Study Ongoing 24 Sep 2020
CAIN457A2318: A randomized, double-blind, placebo controlled, multicenter study of subcutaneous secukinumab, to demonstrate efficacy after twelve weeks of treatment and to assess safety, tolerability . . . Completed 04 Jun 2020
Convalescent Plasma Therapy as Adjunctive Therapy for Hospitalized Patients with COVID-19: Co-CLARITY Trial . . . Pending 24 Aug 2020
Copanlisib and rituximab in relapsed indolent B-cell non-Hodgkin’s lymphoma (iNHL) Ongoing 13 Sep 2018
Copanlisib and rituximab in relapsed indolent B-cell non-Hodgkin’s lymphoma (iNHL) Ongoing 13 Sep 2018
Debio 1347-201 – Phase II basket trial in solid tumors harboring a fusion of FGFR1-3 Terminated 15 Oct 2020
Dexamethasone Posterior Segment Drug Delivery System Versus Laser Photocoagulation in Patients with Diabetic Macular Edema (Ozurdex DME Study 206207-026) . . . Completed 24 Feb 2020
Double-blind, Randomized, Multicenter, Phase III Clinical Study to Compare the Efficacy and to Evaluate the Safety and Immunogenicity of Trastuzumab Biosimilar HLX02 and EU-sourced Herceptin® in Prev . . . Ongoing 07 Oct 2019
DRAMATIC Trial Ongoing 25 Jun 2021
Effects of Brown Rice Consumption on the Metabolic Risk Factors of Non–Communicable Diseases in Selected Filipino Adults: A Randomized Controlled Study  . . . Completed 25 Jul 2019
Efficacy and safety of finerenone in subjects with type 2 diabetes mellitus and diabetic kidney disease . . . Completed 12 Jul 2021
Efficacy and safety of finerenone in subjects with type 2 diabetes mellitus and diabetic kidney disease . . . Completed 12 Jul 2021
Efficacy and safety of finerenone in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease . . . Completed 12 Jul 2021
Efficacy and safety of finerenone in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease . . . Completed 12 Jul 2021
©2021 HERDIN PLUS. All rights reserved. | Contact Us | Keep up to date